AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio - AbbVie News CenterAbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio AbbVie News CenterSee more headlines & perspectives on Google News